Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
VHIR
Menu
Study of safety and effectiveness of topical administration (eye drops) of sitagliptin for treating early stages of diabetic retinopathy (EyeSit@)
Share
Tweet
Share
Pin
Close Menu
VHIR
Home
Six Top Stories
Highlights
Research Areas
Facts & Figures
Partners and Acknowledgements
WIDER
Download Summary
VHIR Annual Report 2021